Sophie Pierce is determined to make the most of her life - however long she may have.

Stockard has completed the interview portion of the competition and is now preparing for on-stage competition, which, for her, begins Wednesday.

KIT-2014 is under development for the treatment of cystic fibrosis, chronic obstructive pulmonary disease and asthma. The therapeutic candidate acts by targeting phosphoinositide 3-kinase gamma. It is ...

Vertex Pharmaceuticals offers promising opportunities in pain management, cystic fibrosis treatments, and a diversified ...

There was severe flooding in the Mid-Ohio Valley at the beginning of April that caused some businesses to go underwater. Two ...

Giving back to the community is also a cornerstone of his life, as he actively supports organizations like the Cystic Fibrosis Foundation and the Make-A-Wish Foundation. "Helping others reminds me of ...

Inogen, Inc. INGN recently announced the FDA 510 (k) clearance for the SIMEOX 200 Airway Clearance Device. The clearance is ...

Sixteen-year-old Kaia Barret lays in a hospital bed for the third day in a row after suffering intense burns and<a ...

The US Food and Drug Administration (FDA) has granted 510 (k) clearance for Inogen’s SIMEOX 200 Airway Clearance Device for ...

PROVIDENCE, R.I. (WLNE) — The Rhode Island General Assembly is turning out a bevy of new laws for 2025. Starting Wednesday, ...

Each child had already undergone at least three open-heart surgeries. They'd endured countless hours in doctors' offices and ...